Meta-analysis: Predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 8, 2011, Pages 888-900

  Garcia Iglesias P ^a   Villoria, A ^a   Suarez, D ^b   Brullet, E ^a,c   Gallach, M ^a   Feu, F ^c,d   Gisbert, J P ^c,e   Barkun, A ^f   Calvet, X ^a,c  

^a PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ARTICLE; BLEEDING; BLEEDING TENDENCY; BLOOD TRANSFUSION; DIGESTIVE TRACT PARAMETERS; DISEASE SEVERITY; DUODENUM ULCER; ENDOSCOPIC THERAPY; HEMATOLOGICAL PARAMETERS; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HUMAN; PEPTIC ULCER BLEEDING; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; STOMACH ULCER; SYSTEMATIC REVIEW;

ENDOSCOPY, GASTROINTESTINAL; HEMOSTASIS, ENDOSCOPIC; HUMANS; ODDS RATIO; PEPTIC ULCER HEMORRHAGE; PROGNOSIS; RECURRENCE; RISK FACTORS;

EID: 80053219700     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04830.x     Document Type: Article

References (62)

1. UK Upper GI Bleeding Audit. UK Comparative Audit of Upper Gastrointestinal Bleeding and the Use of Blood. Available at: http://www.bsg.org.uk/clinical/general/uk-upper-gi-bleeding-audit.html. Accessed December 11, 2009.
2. Barkun A, Sabbah S, Enns R, et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol 2004; 99: 1238-46. (Pubitemid 39062258)
3. Baradarian R, Ramdhaney S, Chapalamadugu R, et al. Early intensive resuscitation of patients with upper gastrointestinal bleeding decreases mortality. Am J Gastroenterol 2004; 99: 619-22. (Pubitemid 38607962)
4. Adler DG, Leighton JA, Davila RE, et al. ASGE guideline: the role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc 2004; 60: 497-504. (Pubitemid 39311529)
5. Barkun A, Bardou M, Marshall JK,. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003; 139: 843-57.
6. Barkun A, Bardou M, Kuipers E, et al. International Consensus Recommendations on the Management of Patients with Non-Variceal Upper Gastrointestinal Bleeding (ICON-UGIB). Ann Intern Med 2010; 152: 101-13.
7. Calvet X, Vergara M, Brullet E, et al. Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers. Gastroenterology 2004; 126: 441-50. (Pubitemid 38182301)
8. Cook DJ, Guyatt GH, Salena BJ, et al. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992; 102: 139-48.
9. Leontiadis GI, Sharma VK, Howden CW,. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2006; 1: CD002094.
10. Sung JJ, Barkun A, Kuipers EJ, et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med 2009; 150: 455-64.
11. Marmo R, Koch M, Cipolletta L, et al. Italian registry on upper gastrointestinal bleeding (ProgettoNazionaleEmorragie Digestive-PNED 2). Predicting mortality in non-variceal upper gastrointestinal bleeders: validation of the Italian PNED Score and Prospective Comparison with the Rockall Score. Am J Gastroenterol 2010; 105: 1284-91.
12. Chiu PW, Ng EK, Cheung FK, et al. Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. Clin Gastroenterol Hepatol 2009; 7: 311-6.
13. Forrest JA, Finlayson ND, Shearman DJ,. Endoscopy in gastrointestinal bleeding. Lancet 1974; 2: 394-7.
14. Spiegel BM, Ofman JJ, Woods K, et al. Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies. Am J Gastroenterol 2003; 98: 86-97. (Pubitemid 36135175)
15. Brullet E, Campo R, Calvet X, et al. A randomized study of the safety of outpatient care for patients with bleeding peptic ulcer treated by endoscopic injection. Gastrointest Endosc 2004; 60: 15-21. (Pubitemid 38842424)
16. Brullet E, Calvet X, Campo R, et al. Clinical judgement versus risk scores for predicting outcome in patients bleeding from high risk peptic ulcer. Preliminary results of a prospective multicenter study. Gastroenterology 2009; 136 (Suppl. 1): A43-4.
17. Camellini L, Merighi A, Pagnini C, et al. Comparison of three different risk scoring systems in non-variceal upper gastrointestinal bleeding. Dig Liver Dis 2004; 36: 271-7. (Pubitemid 41115477)
18. Church NI, Dallal HJ, Masson J, et al. Validity of the Rockall scoring system after endoscopic therapy for bleeding peptic ulcer: a prospective cohort study. Gastrointest Endosc 2006; 63: 606-12.
19. Enns RA, Gagnon YM, Barkun AN, et al. Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting. World J Gastroenterol 2006; 12: 7779-85. (Pubitemid 46099946)
20. Vreeburg EM, Terwee CB, Snel P, et al. Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut 1999; 44: 331-5. (Pubitemid 29119326)
21. Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper gastrointestinal hemorrhage. Gut 1996; 38: 316-21. (Pubitemid 26074312)
22. Barkun AN, Martel M, Toubouti Y, et al. Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest Endosc 2009; 69: 786-99.
23. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001; 20 (Suppl. 3): 21-35. (Pubitemid 33732964)
24. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-12.
25. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60. (Pubitemid 37088507)
26. Elmunzer BJ, Young SD, Inadomi JM, et al. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol 2008; 103: 2625-32.
27. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88. (Pubitemid 17189972)
28. Jaramillo JL, Galvez C, Carmona C, et al. Prediction of further hemorrhage in bleeding peptic ulcer. Am J Gastroenterol 1994; 89: 2135-8. (Pubitemid 24363656)
29. Lin HJ, Perng CL, Lee FY, et al. Clinical courses and predictors for rebleeding in patients with peptic-ulcers and nonbleeding visible vessels-a prospective-study. Gut 1994; 35: 1389-93.
30. Branicki FJ, Coleman SY, Fok PJ, et al. Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg 1990; 14: 262-9.
31. Branicki FJ, Coleman SY, Lam TC, et al. Hypotension and endoscopic stigmata of recent hemorrhage in bleeding peptic ulcer: risk models for rebleeding and mortality. J Gastroenterol Hepatol 1992; 7: 184-90.
32. Al-Akeely MH, Alam MK, Al-Salamah SM, et al. Initial factors predicting rebleeding and death in bleeding peptic ulcer disease. Saudi Med J 2004; 25: 642-7. (Pubitemid 38771847)
33. Hsu PI, Lin XZ, Chan SH, et al. Bleeding peptic-ulcer-risk-factors for rebleeding and sequential-changes in endoscopic findings. Gut 1994; 35: 746-9.
34. Vidal PJ, Pagan PA, Rua GA, et al. Multivariate analysis of the risk of hemorrhagic recurrence in gastroduodenal ulcer. Study of a prospective series. Gastroenterol Hepatol 2000; 23: 422-7.
35. Guglielmi A, Ruzzenente A, Sandri M, et al. Risk assessment and prediction of rebleeding in bleeding gastroduodenal ulcer. Endoscopy 2002; 34: 778-86.
36. Bourienne A, Pagenault M, Heresbach D, et al. Multicenter prospective study of prognostic factors of gastroduodenal ulcer hemorrhages. Reevaluation of clinical and endoscopic factors in the era of endoscopic hemostasis. Gastroenterol Clin Biol 2000; 24: 193-200.
37. Choudari CP, Rajgopal C, Elton RA, et al. Failures of endoscopic therapy for bleeding peptic ulcer: an analysis of risk factors. Am J Gastroenterol 1994; 89: 1968-72. (Pubitemid 24334234)
38. Pundzius J,. Clinical and endoscopic signs for the prediction of recurrent bleeding from gastroduodenal ulcers. Eur J Surg 1994; 160: 689-92. (Pubitemid 24380862)
39. Schilling D, Demel A, Nusse T, et al. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial. Endoscopy 2003; 35: 393-6. (Pubitemid 36559485)
40. Chow LW, Gertsch P, Poon RT, et al. Risk factors for rebleeding and death from peptic ulcer in the very elderly. Br J Surg 1998; 85: 121-4. (Pubitemid 28034130)
41. Chen JJ, Changchien CS, Tai DI, et al. Success of endoscopic injection therapy in correlation with maximal one-day transfusion requirement. Endoscopy 1995; 27: 298-303.
42. Travis AC, Wasan SK, Saltzman JR,. Model to predict rebleeding following endoscopic therapy for non-variceal upper gastrointestinal hemorrhage. J Gastroenterol Hepatol 2008; 23: 1505-10.
43. Chiu PW, Joeng HK, Choi CL, et al. Predictors of peptic ulcer rebleeding after scheduled second endoscopy: clinical or endoscopic factors? Endoscopy 2006; 38: 726-9. (Pubitemid 44044402)
44. Saeed ZA, Winchester CB, Michaletz PA, et al. A scoring system to predict rebleeding after endoscopic therapy of nonvariceal upper gastrointestinal hemorrhage, with a comparison of heat probe and ethanol injection. Am J Gastroenterol 1993; 88: 1842-9. (Pubitemid 23324397)
45. Thomopoulos KC, Theocharis GJ, Vagenas KA, et al. Predictors of hemostatic failure after adrenaline injection in patients with peptic ulcers with non-bleeding visible vessel. Scand J Gastroenterol 2004; 39: 600-4. (Pubitemid 38916268)
46. GarciaSanchez MV, Lopez VP, Gonzalez GA, et al. Factors associated with failure of endoscopic therapy in gastric ulcer bleeding. Gastroenterol Hepatol 2003; 26: 227-33.
47. Lopez VP, GarciaSanchez MV, Gonzalez GA, et al. Failure of endoscopic therapy in upper gastrointestinal hemorrhage due to duodenal ulcers. Rev Esp Enferm Dig 2003; 95: 700-9.
48. Brullet E, Campo R, Calvet X, et al. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut 1996; 39: 155-8. (Pubitemid 26275987)
49. Brullet E, Calvet X, Campo R, et al. Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer. Gastrointest Endosc 1996; 43: 111-6. (Pubitemid 26065494)
50. Villanueva C, Balanzo J, Espinos JC, et al. Prediction of therapeutic failure in patients with bleeding peptic ulcer treated with endoscopic injection. Dig Dis Sci 1993; 38: 2062-70. (Pubitemid 23336572)
51. Wong SK, Yu LM, Lau JY, et al. Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer. Gut 2002; 50: 322-5. (Pubitemid 34161045)
52. Chung IK, Kim EJ, Lee MS, et al. Endoscopic factors predisposing to rebleeding following endoscopic hemostasis in bleeding peptic ulcers. Endoscopy 2001; 33: 969-75. (Pubitemid 33034735)
53. Thomopoulos KC, Mitropoulos JA, Katsakoulis EC, et al. Factors associated with failure of endoscopic injection hemostasis in bleeding peptic ulcers. Scand J Gastroenterol 2001; 36: 664-8. (Pubitemid 32424261)
54. Park KG, Steele RJ, Mollison J, et al. Prediction of recurrent bleeding after endoscopic hemostasis in non-variceal upper gastrointestinal hemorrhage. Br J Surg 1994; 81: 1465-8. (Pubitemid 24305991)
55. Huang YS, Lin HJ, Fang YR, et al. Development and validation of a scoring system predicting failure of endoscopic epinephrine injection therapy in Taiwanese patients with bleeding peptic ulcers. Zhonghua Yi XueZaZhi (Taipei) 2002; 65: 144-50.
56. Lin HJ, Tseng GY, Lo WC, et al. Predictive factors for rebleeding in patients with peptic ulcer bleeding after multipolar electrocoagulation: a retrospective analysis. J Clin Gastroenterol 1998; 26: 113-6.
57. Majid S, Ahmed A, Jafri W, Nasir A,. Predictors of rebleed in actively bleeding duodenal ulcer after endoscopic intervention in a developing Asian Country. Am J Gastroenterol 2007; 102 (Suppl. 2): S 520.
58. Toki M, Yamaguchi Y, Nakamura K, et al. Predictive risk factors por rebleeding and thirty day mortality after endoscopic hemostasis in elderly bleeding peptic ulcer patients. Gastrointest Endosc 2008; 67: AB240.
59. Straker RJ, Bienvenu JC, Nord HJ,. Endoscopic orientation within the duodenal bulb. Endoscopy 1992; 24: 266-7.
60. Sonnenberg A, Giger M, Kern L, et al. How reliable is determination of ulcer size by endoscopy? BMJ 1979; 2: 1322-4. (Pubitemid 10209573)
61. Hu ML, Wu KL, Chiu KW, et al. Predictors of rebleeding after initial hemostasis with epinephrine injection in high-risk ulcers. World J Gastroenterol 2010; 16: 5490-5.
62. Cheng CL, Lin CH, Kuo CJ, et al. Predictors of rebleeding and mortality in patients with high-risk bleeding peptic ulcers. Dig Dis Sci 2010; 9: 2577-83.